Health
New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2 – News-Medical.Net
In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-C…
In a groundbreaking bioRxiv* study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.
In response to the ongoing health crisis brought by th…
-
Noosa News19 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General23 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News12 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General12 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final